Related references
Note: Only part of the references are listed.Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
Franz X. Schaub et al.
BLOOD (2010)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
Nils H. Thoennissen et al.
BLOOD (2010)
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine O'Keefe et al.
BLOOD (2010)
Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
Omar Abdel-Wahab et al.
CANCER RESEARCH (2010)
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
Olivier Kosmider et al.
BLOOD (2009)
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
Anna M. Jankowska et al.
BLOOD (2009)
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Olivier Kosmider et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
Azim M. Mohamedali et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
A. Tefferi et al.
LEUKEMIA (2009)
TET2 mutations in myelodysplasia and myeloid malignancies
Charles G. Mullighan
NATURE GENETICS (2009)
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
Damla Olcaydu et al.
NATURE GENETICS (2009)
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Outi Kilpivaara et al.
NATURE GENETICS (2009)
Acquired mutations in TET2 are common in myelodysplastic syndromes
Saskia M. C. Langemeijer et al.
NATURE GENETICS (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Myelodysplastic syndromes: molecular pathogenesis and genomic changes
Florian Nolte et al.
ANNALS OF HEMATOLOGY (2008)
Whole genome scanning as a cytogenetic tool in hematologic malignancies
Jaroslaw P. Maciejewski et al.
BLOOD (2008)
Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome
A. M. Jankowska et al.
LEUKEMIA (2008)
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Lukasz P. Gondek et al.
BLOOD (2008)
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali et al.
BLOOD (2007)
Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation
Elizabeth C. Wolstencroft et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K. Thomas et al.
NATURE MEDICINE (2006)
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
RB Lorsbach et al.
LEUKEMIA (2003)
Share Paper
